Sharad Ghamande

Acting Director

Sharad Ghamande

Acting Director


Academic Appointment(s)

Medical College of Georgia
Department of Obstetrics and Gynecology

Other Duties

Executive Vice Chair, Obstetrics and Gynecology, Gynecologic Oncology

Section Chief, Obstetrics and Gynecology, Gynecologic Oncology

Director, Cancer Service Line


I am Professor, Executive Vice Chair, and Director for Gynecological Oncology at Augusta University (Georgia Regents University (GRU) at Augusta, Georgia and have been heavily involved in clinical trials for over 16 years. I am also the Associate Cancer Center Director for Clinical Research. I sincerely believe that clinical trials and health care delivery research leads the way to improvements in patient’s outcomes in both quality of life and survival. As an oncologist, I have always strived to bring new options to our patients, educate them about the process and empower them to make choices that could better their care, and perhaps advance progress in cancer treatments. In Augusta, over 40% of our patients are African American (AA) in origin and are often underserved. The new NCORP M\U grant will help all of us in getting these patients, who often are underrepresented in clinical trials, to be a part of them. The emphasis on health care delivery and disparity research is long overdue, as emerging data is clearly showing differences in both response to treatments and access to good health care based on race, and our patient mix positions us to play an important part in this endeavor.

  • (706) 721-3591
  • BA 7411A


  • MD, Obstetrics and Gynecology Univ of Bombay, 1991

  • MBBS, Medicine Univ of Bombay, 1985


  • Da Vinci Robitics 2008

  • AOAOG American Board of Obstetrics, 2010

  • PHY State Bd. of Medical Examiners, 2000

Awards & Honors

  • Best Doctors in America 2017

  • Top Doctors for Cancer in America 2017

  • Distinguished Faculty Award Medical College of Georgia, Faculty Senate, AU, 2017

  • Distinguished Doctor Expert Network, 2016

Courses Taught Most Recent Academic Year

  • OBGN 5000

    Basic Clkshp OBG 6 wks
  • OBGN 5007

    Gynecologic Oncology Extn.
  • OBGN 5009

    OB/GYN Sub-I
  • ROBG 5000

    Obstetrics and Gynecology

Teaching Interests

Resident and student teaching Mentoring and training GYN Oncology Fellow


Selected Recent Publications

  • Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma, 2015
    Journal Article, Academic Journal
  • A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors, 2014
    Journal Article, Academic Journal
  • Twelve serum proteins progressively increase with disease stage in squamous cell cervical cancer patients, 2014
    Journal Article, Academic Journal
  • Twelve serum proteins progressively increase with disease stage in squamous cell cervical cancer patients, 2014
    Journal Article, Academic Journal
  • Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: The phase III OVATURE multicenter randomized study, 2014
    Journal Article, Academic Journal

Research Interests

Multiple grants GYN Oncology trials including investigator initiated trials. Increased patient accrual to NCORP

Professional Service

  • - 2015

    Role: Reviewer, Ad Hoc Reviewer